Survey on Epilepsy-Dyskinesia in Children

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

Recruiting Observational Study
Epilepsy in Children Dyskinesias Movement Disorders in Children Neurologic Disorder Chorea Myoclonus Ataxia Epilepsy Dystonia Disorder Movement Disorders
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
0 – 18
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Boston Children's Hospital · Other
Who this trial is looking for

This trial is looking for children with movement disorders who have certain genetic changes related to epilepsy. Participants will help researchers gather information about these conditions through a survey.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a child between 0-18 years old
  • I have a movement disorder
  • I have a pathogenic or likely pathogenic genetic variant in specific genes

You may not be able to join if

  • I do not have a diagnosed movement disorder

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Epilepsy-Dyskinesia Study aims to advance the understanding of the clinical and molecular spectrum of epilepsy-dyskinesia syndromes, monogenic diseases that cause both movement disorders and epilepsy. Addressing challenges in rare disease research -such as small, geographically dispersed patient populations and a lack of standardized protocols- the study employs a multinational retrospective s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Children between 0 - 18 years of age with a movement disorder and a pathogenic or likely pathogenic variant in one of the genes of interest: AARS2 ALG13 AP3B2 AP4B1 AP4E1 AP4M1 AP4S1 ARX ATP1A3 CACNA1A CACNA1E CACNA2D2 CDKL5 CSTB DARS2 DLAT DLD DNM1 EARS2 EPG5 FARS2 FOXG1 FRR…
Contacts

Darius Ebrahimi-Fakhari, MD, PhD.

617-355-0097

movementdisorders@childrens.harvard.edu

CONTACT

Vicente Quiroz, MD

movementdisorders@childrens.harvard.edu

CONTACT